| Hongyan Liang, MD | |
|
2 Capital Way Ste 220, Pennington, NJ 08534-2523 | |
| (609) 303-0747 | |
| (609) 303-0771 |
| Full Name | Hongyan Liang |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 27 Years |
| Location | 2 Capital Way Ste 220, Pennington, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194931568 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Capital Health Medical Center - Hopewell | Pennington, NJ | Hospital |
| Capital Health Regional Medical Center | Trenton, NJ | Hospital |
| Robert Wood Johnson University Hospital At Hamilton | Hamilton, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Capital Health Medical Group | 7618264532 | 364 |
| Capital Health Medical Group | 7618264532 | 364 |
News Archive
Acute myeloid leukemia (AML) is a group of heterogeneous diseases with considerable diversity in terms of genetic abnormalities. Mutations of CEBPA, a tumour suppressor, are found in about 10 per cent of human AML patients. In two separate studies on CEBPA mutations in AML subtypes, researchers successfully identified and validated a gene known as Sox4 as a potential therapeutic target and a class of anti-cancer drugs, histone deacetylase (HDAC) inhibitors, as potential candidates in the treatment of certain AML.
University of Manchester researchers found that a special type of the chemicals known as 'kinase inhibitors' opened up communication channels on the surface of cells that enabled healthy cells to 'talk' to the cancer cells.
Miltenyi Biotec, the only company to offer a seamless experimental integration path from sample preparation through cell separation, culture, and analysis for primary cells, today entered into a strategic alliance with TeutoCell, a provider of cutting edge cell culture technology.
The United Steelworkers said today that Wednesday's fire at ExxonMobil's Baton Rouge, La., refinery that injured one employee and two contractors demonstrates the urgency of the union's call for greater attention to process safety within the refining sector. This incident follows less than two weeks after the deadly Tesoro refinery explosion in Anacortes, Wash.
The immune system of a pregnant woman is altered during pregnancy, but not in the way previously believed, according to results from a study at Linköping University, Sweden.
› Verified 4 days ago
| Entity Name | Mercer Bucks Hematology/oncology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558375535 PECOS PAC ID: 1052311677 Enrollment ID: O20070105000038 |
News Archive
Acute myeloid leukemia (AML) is a group of heterogeneous diseases with considerable diversity in terms of genetic abnormalities. Mutations of CEBPA, a tumour suppressor, are found in about 10 per cent of human AML patients. In two separate studies on CEBPA mutations in AML subtypes, researchers successfully identified and validated a gene known as Sox4 as a potential therapeutic target and a class of anti-cancer drugs, histone deacetylase (HDAC) inhibitors, as potential candidates in the treatment of certain AML.
University of Manchester researchers found that a special type of the chemicals known as 'kinase inhibitors' opened up communication channels on the surface of cells that enabled healthy cells to 'talk' to the cancer cells.
Miltenyi Biotec, the only company to offer a seamless experimental integration path from sample preparation through cell separation, culture, and analysis for primary cells, today entered into a strategic alliance with TeutoCell, a provider of cutting edge cell culture technology.
The United Steelworkers said today that Wednesday's fire at ExxonMobil's Baton Rouge, La., refinery that injured one employee and two contractors demonstrates the urgency of the union's call for greater attention to process safety within the refining sector. This incident follows less than two weeks after the deadly Tesoro refinery explosion in Anacortes, Wash.
The immune system of a pregnant woman is altered during pregnancy, but not in the way previously believed, according to results from a study at Linköping University, Sweden.
› Verified 4 days ago
| Entity Name | Capital Health Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437516887 PECOS PAC ID: 7618264532 Enrollment ID: O20160921000449 |
News Archive
Acute myeloid leukemia (AML) is a group of heterogeneous diseases with considerable diversity in terms of genetic abnormalities. Mutations of CEBPA, a tumour suppressor, are found in about 10 per cent of human AML patients. In two separate studies on CEBPA mutations in AML subtypes, researchers successfully identified and validated a gene known as Sox4 as a potential therapeutic target and a class of anti-cancer drugs, histone deacetylase (HDAC) inhibitors, as potential candidates in the treatment of certain AML.
University of Manchester researchers found that a special type of the chemicals known as 'kinase inhibitors' opened up communication channels on the surface of cells that enabled healthy cells to 'talk' to the cancer cells.
Miltenyi Biotec, the only company to offer a seamless experimental integration path from sample preparation through cell separation, culture, and analysis for primary cells, today entered into a strategic alliance with TeutoCell, a provider of cutting edge cell culture technology.
The United Steelworkers said today that Wednesday's fire at ExxonMobil's Baton Rouge, La., refinery that injured one employee and two contractors demonstrates the urgency of the union's call for greater attention to process safety within the refining sector. This incident follows less than two weeks after the deadly Tesoro refinery explosion in Anacortes, Wash.
The immune system of a pregnant woman is altered during pregnancy, but not in the way previously believed, according to results from a study at Linköping University, Sweden.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hongyan Liang, MD 2 Capital Way Ste 220, Pennington, NJ 08534-2523 Ph: (609) 303-0747 | Hongyan Liang, MD 2 Capital Way Ste 220, Pennington, NJ 08534-2523 Ph: (609) 303-0747 |
News Archive
Acute myeloid leukemia (AML) is a group of heterogeneous diseases with considerable diversity in terms of genetic abnormalities. Mutations of CEBPA, a tumour suppressor, are found in about 10 per cent of human AML patients. In two separate studies on CEBPA mutations in AML subtypes, researchers successfully identified and validated a gene known as Sox4 as a potential therapeutic target and a class of anti-cancer drugs, histone deacetylase (HDAC) inhibitors, as potential candidates in the treatment of certain AML.
University of Manchester researchers found that a special type of the chemicals known as 'kinase inhibitors' opened up communication channels on the surface of cells that enabled healthy cells to 'talk' to the cancer cells.
Miltenyi Biotec, the only company to offer a seamless experimental integration path from sample preparation through cell separation, culture, and analysis for primary cells, today entered into a strategic alliance with TeutoCell, a provider of cutting edge cell culture technology.
The United Steelworkers said today that Wednesday's fire at ExxonMobil's Baton Rouge, La., refinery that injured one employee and two contractors demonstrates the urgency of the union's call for greater attention to process safety within the refining sector. This incident follows less than two weeks after the deadly Tesoro refinery explosion in Anacortes, Wash.
The immune system of a pregnant woman is altered during pregnancy, but not in the way previously believed, according to results from a study at Linköping University, Sweden.
› Verified 4 days ago
Neil Saxena, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2 Capital Way Ste 385, Pennington, NJ 08534 Phone: 609-303-4838 Fax: 609-303-4835 | |
Madhuri Adabala, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1 Capital Way, Pennington, NJ 08534 Phone: 609-303-4000 | |
Mowyad Omer Elamin Khalid, M.D Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 2 Capital Way Ste 550, Pennington, NJ 08534 Phone: 609-303-4360 Fax: 609-303-4361 | |
Rishi Patel, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2 Capital Way Ste 550, Pennington, NJ 08534 Phone: 609-303-4360 | |
Dr. Brian Adam Meltzer, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 6 E Acres Dr, Pennington, NJ 08534 Phone: 609-737-1903 Fax: 732-247-5309 | |
Marie Antoinette Marquez, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1300 Merrill Lynch Dr, Pennington, NJ 08534 Phone: 609-274-6000 | |
Anita Maraj, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1 Capital Way, Pennington, NJ 08534 Phone: 609-303-4000 |